Aortic Complications in Marfan Syndrome: Should We Anticipate Preventive Aortic Root Surgery?


Journal

The Annals of thoracic surgery
ISSN: 1552-6259
Titre abrégé: Ann Thorac Surg
Pays: Netherlands
ID NLM: 15030100R

Informations de publication

Date de publication:
06 2020
Historique:
received: 28 03 2019
revised: 27 07 2019
accepted: 26 08 2019
pubmed: 8 10 2019
medline: 13 8 2020
entrez: 8 10 2019
Statut: ppublish

Résumé

The purpose of this study was to analyze the risk of aortic events (death, dissection, or aortic rupture) associated with Marfan syndrome and decide on the optimal timing for preventive surgery on the aortic root. From January 2004 to June 2015, 397 patients from Marfan Units were studied by echocardiographic and computed tomography and magnetic resonance imaging of aorta and periodic annual monitoring. Mean follow-up was 5.6 ± 2.7 years. The annual incidence of aortic events was assessed according to aortic diameters for the optimal time for prophylactic surgery to be decided on. Mean age at the first visit was 28.4 ± 14.5 years, with mean sinuses of Valsalva diameter of 37.1 ± 6.6 mm., Eleven aortic events occurred during follow-up: seven deaths and four acute aortic dissections. Mean annual risk of an aortic event was 0.5% (risk of death 0.32% and risk of aortic dissection 0.18%). The increase in aortic diameters was associated with increased risk of 0.2% per year (95% confidence interval [CI], 0.03 to 0.5) with diameters less than 40 mm, 0.3% per year (95% CI, 0.1 to 1.4) between 40 and 44 mm, 1.3% per year (95% CI, 0.3 to 4.6) between 45 and 49 mm, and 5.2% per year (95% CI, 0.4 to 12.4) with diameters 50 mm or greater. Fifty-six patients underwent elective surgery with no inhospital mortality. Overall survival at 3, 5, and 10 years was 99% ± 5%, 98.6% ± 6%, and 95.5% ± 2.5%, respectively. The incidence of aortic events in patients with Marfan syndrome followed at specific units is low, although the risk increases with aortic diameters of 45 mm or greater. These results support current indications, but we consider it reasonable at experienced centers (elective root aortic surgery mortality less than 1%) to indicate an early surgery when the aortic root exceeds 45 mm.

Sections du résumé

BACKGROUND
The purpose of this study was to analyze the risk of aortic events (death, dissection, or aortic rupture) associated with Marfan syndrome and decide on the optimal timing for preventive surgery on the aortic root.
METHODS
From January 2004 to June 2015, 397 patients from Marfan Units were studied by echocardiographic and computed tomography and magnetic resonance imaging of aorta and periodic annual monitoring. Mean follow-up was 5.6 ± 2.7 years. The annual incidence of aortic events was assessed according to aortic diameters for the optimal time for prophylactic surgery to be decided on.
RESULTS
Mean age at the first visit was 28.4 ± 14.5 years, with mean sinuses of Valsalva diameter of 37.1 ± 6.6 mm., Eleven aortic events occurred during follow-up: seven deaths and four acute aortic dissections. Mean annual risk of an aortic event was 0.5% (risk of death 0.32% and risk of aortic dissection 0.18%). The increase in aortic diameters was associated with increased risk of 0.2% per year (95% confidence interval [CI], 0.03 to 0.5) with diameters less than 40 mm, 0.3% per year (95% CI, 0.1 to 1.4) between 40 and 44 mm, 1.3% per year (95% CI, 0.3 to 4.6) between 45 and 49 mm, and 5.2% per year (95% CI, 0.4 to 12.4) with diameters 50 mm or greater. Fifty-six patients underwent elective surgery with no inhospital mortality. Overall survival at 3, 5, and 10 years was 99% ± 5%, 98.6% ± 6%, and 95.5% ± 2.5%, respectively.
CONCLUSIONS
The incidence of aortic events in patients with Marfan syndrome followed at specific units is low, although the risk increases with aortic diameters of 45 mm or greater. These results support current indications, but we consider it reasonable at experienced centers (elective root aortic surgery mortality less than 1%) to indicate an early surgery when the aortic root exceeds 45 mm.

Identifiants

pubmed: 31589859
pii: S0003-4975(19)31488-2
doi: 10.1016/j.athoracsur.2019.08.096
pii:
doi:

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1850-1857

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2020 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Auteurs

Carlos Martín (C)

Servicio de Cirugía Cardiaca, Hospital Universitario Puerta de Hierro, Madrid, Spain. Electronic address: carlosestebanmartin@hotmail.com.

Arturo Evangelista (A)

Servicio de Cardiología, Hospital Universitario Vall d'Hebrón, Barcelona, Spain.

Santiago Serrano-Fiz (S)

Servicio de Cirugía Cardiaca, Hospital Universitario Puerta de Hierro, Madrid, Spain.

Susana Villar (S)

Servicio de Cirugía Cardiaca, Hospital Universitario Puerta de Hierro, Madrid, Spain.

Victor Ospina (V)

Servicio de Cirugía Cardiaca, Hospital Universitario Puerta de Hierro, Madrid, Spain.

Daniel Martínez (D)

Servicio de Cirugía Cardiaca, Hospital Universitario Puerta de Hierro, Madrid, Spain.

Juan De Villarreal (J)

Servicio de Cirugía Cardiaca, Hospital Universitario Puerta de Hierro, Madrid, Spain.

Violeta Sanchez (V)

Servicio de Cardiología, Hospital Universitario 12 de Octubre, Madrid, Spain.

Vanessa Moñivas (V)

Servicio de Cardiología, Hospital Universitario Puerta de Hierro, Madrid, Spain.

Susana Mingo (S)

Servicio de Cardiología, Hospital Universitario Puerta de Hierro, Madrid, Spain.

Alberto Forteza (A)

Servicio de Cirugía Cardiaca, Hospital Universitario Puerta de Hierro, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH